Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients

BACKGROUND: Predicting imminent hepatocellular carcinoma (HCC) in liver cirrhotic patients is an unmet medical need. We aimed to investigate circulatory biomarkers and their optimum combinations in a prospective study. METHODS: We investigated plasma interleukin 17 (IL-17) concentrations, quantified...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Kung-Hao, Lai, Ming-Wei, Lin, Yang-Hsiang, Chu, Yu-De, Lin, Chih-Lang, Lin, Wey-Ran, Huang, Ya-Hui, Wang, Tong-Hung, Chien, Rong-Nan, Hu, Tsung-Hui, Yeh, Chau-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052794/
https://www.ncbi.nlm.nih.gov/pubmed/33865328
http://dx.doi.org/10.1186/s12876-021-01761-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052794/
https://www.ncbi.nlm.nih.gov/pubmed/33865328
http://dx.doi.org/10.1186/s12876-021-01761-1

Ejemplares similares